The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H
- PMID: 8643100
- DOI: 10.1016/0161-5890(95)00118-2
The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H
Abstract
A monoclonal human IgG1, Campath-1H, was digested with glycosidases to assess the effect of carbohydrate on the functional activities of an IgG1. Removal of the complete carbohydrate moiety abolished complement lysis activity and antibody-dependent cell-mediated cytotoxicity, but left antigen binding activity and protein A binding activity intact. Removal of terminal sialic acid residues through glycopeptidase F digestion was not found to affect any of the tested IgG activities. Removal of the majority of the galactose residues from desialylated Campath-1H was found to reduce but not abolish complement lysis activity. Other activities were not affected by degalactosylation. This indicates a rare separation of complement lysis activity and antibody-dependent cell-mediated cytotoxicity of IgG in the way they behave under controlled conditions. This paper underlines the overall importance of carbohydrate in IgG function and stresses the relative contributions of some of the carbohydrate residues.
Similar articles
-
Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose.Anal Biochem. 1997 Apr 5;247(1):102-10. doi: 10.1006/abio.1997.2036. Anal Biochem. 1997. PMID: 9126378
-
Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material.Clin Exp Immunol. 1992 Jan;87(1):105-10. doi: 10.1111/j.1365-2249.1992.tb06421.x. Clin Exp Immunol. 1992. PMID: 1339322 Free PMC article.
-
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29. Glycobiology. 2007. PMID: 17012310
-
Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.J Pharm Sci. 2015 Jun;104(6):1866-1884. doi: 10.1002/jps.24444. Epub 2015 Apr 14. J Pharm Sci. 2015. PMID: 25872915 Review.
-
Beta-1,4-galactosylation of N-glycans is a complex process.Biochim Biophys Acta. 1999 Dec 6;1473(1):54-66. doi: 10.1016/s0304-4165(99)00169-5. Biochim Biophys Acta. 1999. PMID: 10580129 Review.
Cited by
-
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases.Nat Rev Nephrol. 2024 Oct;20(10):672-689. doi: 10.1038/s41581-024-00850-0. Epub 2024 Jul 3. Nat Rev Nephrol. 2024. PMID: 38961307 Review.
-
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.AIDS. 2014 Nov 13;28(17):2523-30. doi: 10.1097/QAD.0000000000000444. AIDS. 2014. PMID: 25160934 Free PMC article.
-
Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody-dependent cellular cytotoxicity.FEBS Open Bio. 2021 Nov;11(11):2943-2949. doi: 10.1002/2211-5463.13267. Epub 2021 Oct 19. FEBS Open Bio. 2021. PMID: 34355537 Free PMC article.
-
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.Arthritis Res Ther. 2017 Aug 9;19(1):182. doi: 10.1186/s13075-017-1389-7. Arthritis Res Ther. 2017. PMID: 28793911 Free PMC article.
-
Recombinant Proteins and Monoclonal Antibodies.Adv Biochem Eng Biotechnol. 2021;175:281-318. doi: 10.1007/10_2017_32. Adv Biochem Eng Biotechnol. 2021. PMID: 29071407 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources